Nature News
-
![[:es]Cancer drugs are closing in on some of the deadliest mutations[:]](https://katedra.eus/app/uploads/2022/06/png-1-17.png)
[:es]Cancer drugs are closing in on some of the deadliest mutations[:]
The protein KRAS, mutated in many cancers, was deemed ‘undruggable’. Now scientists are hoping to save lives with a batch of new compounds that target it.
-
[:es]Cancer drugs are closing in on some of the deadliest mutations[:]
The protein KRAS, mutated in many cancers, was deemed ‘undruggable’. Now scientists are hoping to save lives with a batch of new compounds that target it.
-
[:es]Cancer drugs are closing in on some of the deadliest mutations[:]
The protein KRAS, mutated in many cancers, was deemed ‘undruggable’. Now scientists are hoping to save lives with a batch of new compounds that target it.
-
![[:es]Faster MRI scan captures brain activity in mice[:]](https://katedra.eus/app/uploads/2021/07/png-1-10.png)
[:es]Faster MRI scan captures brain activity in mice[:]
Improved technique could provide fine-scale insights into how brain regions communicate.
-
[:es]Faster MRI scan captures brain activity in mice[:]
Improved technique could provide fine-scale insights into how brain regions communicate.
-
![[:es]Human ‘mini-brains’ implanted in rats prompt excitement — and concern[:]](https://katedra.eus/app/uploads/2022/06/png-3-7.png)
[:es]Human ‘mini-brains’ implanted in rats prompt excitement — and concern[:]
Rat–human hybrid brains offer new ways to study human neuro disorders, but also raise ethical questions.
-
![[:es]DeepMind AI invents faster algorithms to solve tough maths puzzles[:]](https://katedra.eus/app/uploads/2022/05/png-3-3.png)
[:es]DeepMind AI invents faster algorithms to solve tough maths puzzles[:]
Machine-learning technique improves computing efficiency and could have far-reaching applications.
-
[:es]DeepMind AI invents faster algorithms to solve tough maths puzzles[:]
Machine-learning technique improves computing efficiency and could have far-reaching applications.
-
![[:es]Alzheimer’s drug slows mental decline in trial — but is it a breakthrough?[:]](https://katedra.eus/app/uploads/2022/06/png-2-21.png)
[:es]Alzheimer’s drug slows mental decline in trial — but is it a breakthrough?[:]
Researchers are cautiously optimistic following companies’ announcement of positive results for lecanemab.